GlassScriptPhysician profile
Kelli Iceman
NPI 1386008787
$2,268.80
in general payments reported to CMS, 2019-2025
11 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 81% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $13.10 · 2021: $55.72 · 2022: $134 · 2023: $54.65 · 2024: $525 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182 · Travel and Lodging: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.91 |
| Travel and Lodging | $454.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $858.66 | 2022-2025 | Flexband, Citrefix, Flexband Plus |
| Foundation Medical, LLC | $676.00 | 2025 | |
| Medical Device Business Services, INC. | $189.99 | 2019 | |
| Paragon 28, INC. | $140.92 | 2019-2024 | Phantom Metatarsal Shortening |
| Smith+Nephew, INC. | $124.53 | 2019-2025 | Stravix, Grafix Pl |
| Integra Lifesciences Corporation | $96.44 | 2022 | |
| Treace Medical Concepts, INC. | $70.65 | 2023-2025 | |
| Acera Surgical, INC. | $55.72 | 2021 | |
| Arthrex, INC. | $24.00 | 2025 | |
| Depuy Synthes Sales INC. | $16.35 | 2019 | |
| Solventum Corporation | $15.54 | 2024 | V.A.C. Veraflo Cleanse Choice, Activ.A.C., Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Iceman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.